Found 930 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
We are interested in finding out more about LGBTQ+ individuals people’s beliefs and attitudes and beliefs regarding HIV vaccines and other health-related topics. Our study consists of 9 surveys over a 3-year period. These surveys may be completed online, at any location. Eligible participants will be paid upon the successful completion …
The purpose of this study is to depict single-cell transcriptomic and meta-transcriptomic atlases of induced sputum samples from patients cured of TB to comprehensively characterize host-microbiome interactions. This study will simultaneously characterize the respiratory microbiome and define the diversity of cellular phenotypic and functional characteristics of airway cells after TB …
The purpose of this prospective observational study is to gather practical use data of the Dexcom G7 rtCGM system utilized throughout pregnancy among patients with gestational diabetes (GDM). Primary Study Objective: (1) To generate data on the practical use of rtCGM to manage pregnancy in patients with GDM (2) To …
Millions of women worldwide have accidental leakage of urine they cannot control after giving birth. Dealing with this problem can be embarrassing and can even add to feelings of anxiety or depression. If you are experiencing this sort of bothersome accidental bladder leakage, the University of Pennsylvania Health System care …
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery is effective in treating NSCLC for participants not achieving pathological complete response. The primary hypothesis of this study is sacituzumab tirumotecan plus pembrolizumab is superior to pembrolizumab monotherapy with respect to disease free survival (DFS) as assessed by …
This is a multicenter, open-label extension of the ION-682884-CS2 Study (CARDIO-TTRansform) and of the ISIS 420915-CS101 Study. Eligible participants will receive eplontersen once every 4 weeks for up to 36 months or 6 months after eplontersen is approved and available in the site's country, whichever occurs first. Participants will also …
The PK Papyrus Covered Coronary Stent System (PK Papyrus) received approval under a Humanitarian Device Exemption (HDE H170004) from the Food and Drug Administration on September 14, 2018 and is only indicated for treatment of acute perforations of native coronary arteries and coronary bypass grafts in vessels 2.5 to 5.0 …
Researchers at the University of Pennsylvania in the Department of Biostatistics, Epidemiology and Informatics and the Division of Pulmonary, Allergy, and Critical Care Medicine are conducting a study to better understand how blood immune cells, which are involved in allergies and asthma, change in asthma patients who take asthma biologic …
The overall objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery.
